Oxford Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Oxford Asset Management’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-63,076	Closed	-$1.72M	–	2276
2019 Q3	$1.72M	Sell	63,076 -55,120	-47%	-$1.43M	0.04%	632
2019 Q2	$2.84M	Buy	118,196 +5,003	+4%	+$127K	0.06%	475
2019 Q1	$2.99M	Buy	113,193 +24,328	+27%	+$576K	0.07%	396
2018 Q4	$1.74M	Sell	88,865 -66,044	-43%	-$1.29M	0.05%	544
2018 Q3	$3.02M	Sell	154,909 -1,446	-0.9%	-$27.5K	0.06%	434
2018 Q2	$2.58M	Buy	156,355 +11,494	+8%	+$175K	0.05%	506
2018 Q1	$2.06M	Sell	144,861 -17,067	-11%	-$252K	0.04%	558
2017 Q4	$2.39M	Buy	161,928 +15,402	+11%	+$216K	0.05%	486
2017 Q3	$1.84M	Sell	146,526 -50,222	-26%	-$639K	0.04%	657
2017 Q2	$2.33M	Buy	196,748 +19,215	+11%	+$239K	0.05%	531
2017 Q1	$2.62M	Buy	177,533 +110,556	+165%	+$1.79M	0.06%	339
2016 Q4	$1.08M	Sell	66,977 -165,762	-71%	-$3.01M	0.04%	454
2016 Q3	$4.22M	Buy	+232,739	New	+$4.55M	0.13%	178
2016 Q2	–	Sell	-393,265	Closed	-$6.52M	–	931
2016 Q1	$6.52M	Sell	393,265 -189,184	-32%	-$3.31M	0.19%	119
2015 Q4	$13M	Buy	582,449 +397,271	+215%	+$7.73M	0.31%	55
2015 Q3	$3.67M	Sell	185,178 -58,063	-24%	-$1.83M	0.12%	182
2015 Q2	$8.45M	Sell	243,241 -558,588	-70%	-$17M	0.23%	98
2015 Q1	$20.8M	Buy	801,829 +292,058	+57%	+$5.35M	0.53%	25
2014 Q4	$6.49M	Buy	+509,771	New	+$6.38M	0.14%	148
2014 Q2	–	Sell	-1,063,027	Closed	-$16.1M	–	823
2014 Q1	$16.1M	Buy	1,063,027 +669,434	+170%	+$7.56M	0.47%	38
2013 Q4	$3M	Buy	+393,593	New	+$2.12M	0.08%	345

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Oxford Asset Management's HZNP Position: Q4 2019 in Review

Oxford Asset Management sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2019, closing a stake of 63,076 shares — an estimated $1.72M sold.

Oxford Asset Management first reported a position in HZNP in Q4 2013 and held it in 21 quarters. The position peaked at $20.8M in Q1 2015. 281 funds tracked by Wall St. Rank hold HZNP as of Q4 2019.

Oxford Asset Management reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2019 after selling out during the quarter.
Oxford Asset Management sold 63,076 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2019, an estimated $1.72M.
Oxford Asset Management first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2013 and held it in 21 quarters.
Oxford Asset Management's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $20.8M in Q1 2015.
281 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2019.

Based on Oxford Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.